Sweden: Merck Sharp & Dohme v. Paranova, T 2694-14, District Court of Stockholm, 18 June 2015

Kluwer Patent Blog
May 13, 2016

Please refer to this post as: , ‘Sweden: Merck Sharp & Dohme v. Paranova, T 2694-14, District Court of Stockholm, 18 June 2015’, Kluwer Patent Blog, May 13 2016, http://patentblog.kluweriplaw.com/2016/05/13/sweden-merck-sharp-dohme-v-paranova-t-2694-14-district-court-of-stockholm-t-2694-14-18-june-2015/


In February 2014, Merck Sharp & Dohme Corp. (“MSD”) brought proceedings against Paranova Läkemedel AB (“Paranova”), alleging that Paranova was violating MSD’s right as an exclusive licensee of the European patent EP 0 595 935 (“EP 935”) by taking preparatory measures for parallel importation. MSD applied for a permanent injunction and corrective measures as well as a preliminary injunction. The Stockholm District Court granted a permanent injunction and held that the approved application for authorization of parallel importation from the European Medicines Agency (EMA) was considered to constitute imminent infringement.

A full summary of this case has been published on Kluwer IP Law.